Ask AI

Reaching New Heights in Cardio–Renal–Metabolic Care: Optimizing Treatment to Elevate Patient Outcomes

Learn how to recognize the gaps in care patients with cardio–renal–metabolic (CRM) syndrome face and close these gaps by applying the latest data on SGLT2 inhibitors and other therapies to develop personalized care plans that improve outcomes for those with CRM syndrome, through expert-written ClinicalThought commentaries, downloadable slides, and an on-demand webcast.

Share

Program Content

Events

Activities

New Heights in CRM Slides
Reaching New Heights in Cardio–Renal–Metabolic Care: Optimizing Treatment to Elevate Patient Outcomes
Slideset
Congratulations: You achieved a completion on 04/09/2022

Released: March 11, 2026

Provided by

ProCE Banner

Provided by Clinical Care Options, LLC dba Decera Clinical Education

Supporters

This activity is supported by an independent medical educational grant from Boehringer Ingelheim Pharmaceuticals, Inc. and Eli Lilly and Company.

Boehringer Ingelheim Pharmaceuticals, Inc.

Eli Lilly and Company